Jounce Therapeutics to Present Phase 1 Data from JTX-2011 ICONIC Trial at 2017 American Society of Clinical Oncology Annual Meeting

Rhythm Expands Phase 2 Clinical Trials of Setmelanotide to the Treatment of Bardet-Biedl Syndrome Obesity

CytomX Announces Management Team Changes

Editas Medicine Announces First Quarter 2017 Results and Update

Editas Medicine Demonstrates First Achievement of In Vivo Editing in Non-human Primate Retinas